These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 36587472

  • 1. Chemosaturation for primary and secondary liver malignancies: A comprehensive update of current evidence.
    Vogel A, Ochsenreither S, Zager JS, Wacker F, Saborowski A.
    Cancer Treat Rev; 2023 Feb; 113():102501. PubMed ID: 36587472
    [Abstract] [Full Text] [Related]

  • 2. Chemosaturation with percutaneous hepatic perfusion of melphalan for liver-dominant metastatic uveal melanoma: a single center experience.
    Artzner C, Mossakowski O, Hefferman G, Grosse U, Hoffmann R, Forschner A, Eigentler T, Syha R, Grözinger G.
    Cancer Imaging; 2019 May 30; 19(1):31. PubMed ID: 31146793
    [Abstract] [Full Text] [Related]

  • 3. Percutaneous isolated hepatic perfusion (chemosaturation) with melphalan following right hemihepatectomy in patients with cholangiocarcinoma and metastatic uveal melanoma: peri- and post-interventional adverse events and therapy response compared to a matched group without prior liver surgery.
    Dewald CLA, Becker LS, Maschke SK, Meine TC, Alten TA, Kirstein MM, Vogel A, Wacker FK, Meyer BC, Hinrichs JB.
    Clin Exp Metastasis; 2020 Dec 30; 37(6):683-692. PubMed ID: 33034815
    [Abstract] [Full Text] [Related]

  • 4. Chemosaturation with Percutaneous Hepatic Perfusion: Outcome and Safety in Patients with Metastasized Uveal Melanoma.
    Dewald CLA, Hinrichs JB, Becker LS, Maschke S, Meine TC, Saborowski A, Schönfeld LJ, Vogel A, Kirstein MM, Wacker FK.
    Rofo; 2021 Aug 30; 193(8):928-936. PubMed ID: 33535258
    [Abstract] [Full Text] [Related]

  • 5. Chemosaturation of the Liver - an Update.
    Ebel S, Struck MF, van Boemmel F, Beeskow AB, Gößmann H, Denecke T.
    Rofo; 2023 Jan 30; 195(1):30-37. PubMed ID: 35977553
    [Abstract] [Full Text] [Related]

  • 6. Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma.
    Schönfeld L, Hinrichs JB, Marquardt S, Voigtländer T, Dewald C, Koppert W, Manns MP, Wacker F, Vogel A, Kirstein MM.
    J Cancer Res Clin Oncol; 2020 Nov 30; 146(11):3003-3012. PubMed ID: 32564137
    [Abstract] [Full Text] [Related]

  • 7. Repeated percutaneous hepatic perfusion with melphalan can maintain long-term response in patients with liver cancers.
    Veelken R, Maiwald B, Strocka S, Petersen TO, Moche M, Ebel S, Denecke T, Rehak M, Struck MF, Forstmeyer D, Rademacher S, Seehofer D, Berg T, van Bömmel F.
    Cardiovasc Intervent Radiol; 2022 Feb 30; 45(2):218-222. PubMed ID: 34716470
    [Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of chemosaturation in patients with primary and secondary liver tumors.
    Kirstein MM, Marquardt S, Jedicke N, Marhenke S, Koppert W, Manns MP, Wacker F, Vogel A.
    J Cancer Res Clin Oncol; 2017 Oct 30; 143(10):2113-2121. PubMed ID: 28634727
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies.
    Burgmans MC, de Leede EM, Martini CH, Kapiteijn E, Vahrmeijer AL, van Erkel AR.
    Cardiovasc Intervent Radiol; 2016 Jun 30; 39(6):801-14. PubMed ID: 26718962
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of melphalan, oxaliplatin, and paclitaxel in colon, liver, and gastric cancer cell lines in a short-term exposure model of chemosaturation therapy by percutaneous hepatic perfusion.
    Uzgare RP, Sheets TP, Johnston DS.
    Anticancer Res; 2013 May 30; 33(5):1989-2000. PubMed ID: 23645748
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease.
    Karydis I, Gangi A, Wheater MJ, Choi J, Wilson I, Thomas K, Pearce N, Takhar A, Gupta S, Hardman D, Sileno S, Stedman B, Zager JS, Ottensmeier C.
    J Surg Oncol; 2018 May 30; 117(6):1170-1178. PubMed ID: 29284076
    [Abstract] [Full Text] [Related]

  • 15. Chemosaturation with percutaneous hepatic perfusion for unresectable isolated hepatic metastases from sarcoma.
    Deneve JL, Choi J, Gonzalez RJ, Conley AP, Stewart S, Han D, Werner P, Chaudhry TA, Zager JS.
    Cardiovasc Intervent Radiol; 2012 Dec 30; 35(6):1480-7. PubMed ID: 22699779
    [Abstract] [Full Text] [Related]

  • 16. Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases.
    Tong TML, Fiocco M, van Duijn-de Vreugd JJ, Lutjeboer J, Speetjens FM, Tijl FGJ, Sitsen ME, Zoethout RWM, Martini CH, Vahrmeijer AL, van der Meer RW, van Rijswijk CSP, van Erkel AR, Kapiteijn E, Burgmans MC.
    Cardiovasc Intervent Radiol; 2024 Jun 30; 47(6):741-750. PubMed ID: 38587534
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Over 12 Years Single Institutional Experience Performing Percutaneous Hepatic Perfusion for Unresectable Liver Metastases.
    Carr MJ, Sun J, Cohen JB, Liu J, Serdiuk AA, Stewart SR, Doobay N, Duclos A, Seal DA, Choi J, Zager JS.
    Cancer Control; 2020 Jun 30; 27(1):1073274820983019. PubMed ID: 33372814
    [Abstract] [Full Text] [Related]

  • 20. Predictive Parameters in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan for Unresectable Liver Metastases from Uveal Melanoma: A Retrospective Pooled Analysis.
    Tong TML, Samim M, Kapiteijn E, Meijer TS, Speetjens FM, Brüning R, Schroeder TH, El-Sanosy S, Maschke H, Wacker FK, Vogel A, Dewald CLA, Goeman JJ, Burgmans MC.
    Cardiovasc Intervent Radiol; 2022 Sep 30; 45(9):1304-1313. PubMed ID: 35922562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.